期刊文献+

桃红消癥散对子宫肌瘤模型大鼠雌、孕激素受体表达的影响 被引量:2

Effect of Taohongxiaozheng Powder on the Expression of Estrogen Receptor and Progesterone Receptor in the Rat of Uterine Leiomyoma
原文传递
导出
摘要 目的:研究桃红消癓散对子宫肌瘤模型大鼠雌激素受体(ER)、孕激素受体(PR)及增殖细胞核抗原(PCNA)表达的影响。方法:采用雌孕激素负荷法建立大鼠子宫肌瘤动物模型,通过放免法检测血清雌孕激素水平,观察子宫组织病理改变,免疫组化法观察大鼠子宫平滑肌细胞ER,PR及PCNA的表达。结果:模型大鼠较正常大鼠子宫明显增大,血清性激素水平升高,子宫平滑肌细胞ER,PR及PCNA的表达明显高于正常大鼠。与模型对照组比较,桃红消癓散可降低血清性激素水平,改善子宫组织结构,抑制平滑肌细胞ER,PR及PCNA的表达。结论:桃红消癓散有治疗子宫肌瘤的作用,其机制可能与调节血中雌孕激素水平,抑制子宫平滑肌细胞ER,PR及PCNA的表达有关。 Objective:To investigate the effect of Taohongxiaozheng(THXZ)Powder on the expression of ER,PR and PCNA in the Rat Model of uterine leiomyoma.Methods: The rat model of uterine leiomyoma was established by the method of estrogen and progesterone load.The radioimmuno assay was used to detect the level of serum estrogen and progesterone,the pathological changes in the uterus were observated,and the expression of ER,PR and PCNA of smooth muscle cells were detected by immunohistochemistry technique.Results: The level of serum sex hormone and the expression of ER,PR and PCNA in the model group increased obviously compared with normal group.Comparing with the model group,THXZ Powder could decrease the level of serum sex hormone,improve the organizational structure of the uterus,inhibit the expression of ER,PR and PCNA of smooth muscle cells.Conclusion:The results suggest that THXZ Powder have therapeutic effects of uterine fibroids,which may be related to the regulation of sex hormone and the inhibition of the expression of ER,PR and PCNA of smooth muscle cells.
出处 《中国实验方剂学杂志》 CAS 北大核心 2009年第12期90-93,共4页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 桃红消癓散 子宫肌瘤 雌激素 孕激素 雌激素受体 孕激素受体 增殖细胞核抗原 Taohongxiaozheng Powder uterine leiomyoma estrogen progesterone ER PR PCNA
  • 相关文献

参考文献7

二级参考文献38

  • 1刘雁峰.肌瘤内消丸治疗子宫肌瘤临床研究[J].山东中医学院学报,1995,19(1):30-31. 被引量:7
  • 2姜卫国.黄体酮:在子宫肌瘤发生机理中的重要作用[J].国外医学(妇产科学分册),1996,23(2):95-96. 被引量:28
  • 3李建荣,吴兰生,张广平.大鼠子宫肌瘤两种模型比较与免疫功能的相关性研究[J].中国实验方剂学杂志,2006,12(7):24-27. 被引量:4
  • 4杨进 宋伯来 等.子宫肌瘤患者细胞免疫状态的研究及临床价值[J].广东医学,1993,14(6):337-337.
  • 5Massart F, Becherini L, Marini F, et al. Analysis of estrogen receptor(ER-alpha and ERbeta) and progesterone receptor(PR) polymorphisms in uterine leiomyomas[J]. Med Sci Monit,2003,9(1):25-30.
  • 6Maruo T, Matsuo H, Shimomura Y, et al. Effects of progesterone on growth factor expression in human uterine leiomyoma [J]. Steroids, 2003,68(10-13):817-824.
  • 7Wu X,Wang H,Englund K,et al. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue[J]. Fertil Steril,2002,78(5):985-993.
  • 8Vollenhoven BJ, Hefington AC, Healy DL. Epidermal growth factor and transforming growth factor-beta in uterine fibroids and myometrium[J].Gynecol Obstet Invest, 1995,40(2):120-124.
  • 9Dixon D, He H, Haseman JK. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium[J]. Environ Health Perspect,2000,108(Suppl 5):795-802.
  • 10Poncelet C, Madelenat P, Feldmann G, et al. Expression of von Willebrand g factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas[J]. Fertil Steril,2002,78(3):581-586.

共引文献28

同被引文献72

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部